These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
486 related items for PubMed ID: 30990769
21. Structural insights into a high fidelity variant of SpCas9. Guo M, Ren K, Zhu Y, Tang Z, Wang Y, Zhang B, Huang Z. Cell Res; 2019 Mar; 29(3):183-192. PubMed ID: 30664728 [Abstract] [Full Text] [Related]
22. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race. Liu L, Yin M, Wang M, Wang Y. Mol Cell; 2019 Feb 07; 73(3):611-620.e3. PubMed ID: 30606466 [Abstract] [Full Text] [Related]
24. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9. Hibshman GN, Bravo JPK, Hooper MM, Dangerfield TL, Zhang H, Finkelstein IJ, Johnson KA, Taylor DW. Nat Commun; 2024 Apr 30; 15(1):3663. PubMed ID: 38688943 [Abstract] [Full Text] [Related]
33. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing. Kelkar A, Zhu Y, Groth T, Stolfa G, Stablewski AB, Singhi N, Nemeth M, Neelamegham S. Mol Ther; 2020 Jan 08; 28(1):29-41. PubMed ID: 31601489 [Abstract] [Full Text] [Related]
34. Sequential Activation of Guide RNAs to Enable Successive CRISPR-Cas9 Activities. Clarke R, Terry AR, Pennington H, Hasty C, MacDougall MS, Regan M, Merrill BJ. Mol Cell; 2021 Jan 21; 81(2):226-238.e5. PubMed ID: 33378644 [Abstract] [Full Text] [Related]
35. Protein Inhibitors of CRISPR-Cas9. Bondy-Denomy J. ACS Chem Biol; 2018 Feb 16; 13(2):417-423. PubMed ID: 29251498 [Abstract] [Full Text] [Related]
36. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a. Shin HR, Kweon J, Kim Y. Methods Mol Biol; 2021 Feb 16; 2162():185-193. PubMed ID: 32926383 [Abstract] [Full Text] [Related]
37. A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9. Maji B, Gangopadhyay SA, Lee M, Shi M, Wu P, Heler R, Mok B, Lim D, Siriwardena SU, Paul B, Dančík V, Vetere A, Mesleh MF, Marraffini LA, Liu DR, Clemons PA, Wagner BK, Choudhary A. Cell; 2019 May 02; 177(4):1067-1079.e19. PubMed ID: 31051099 [Abstract] [Full Text] [Related]
38. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor. Kim I, Jeong M, Ka D, Han M, Kim NK, Bae E, Suh JY. Sci Rep; 2018 Mar 01; 8(1):3883. PubMed ID: 29497118 [Abstract] [Full Text] [Related]
39. An engineered ScCas9 with broad PAM range and high specificity and activity. Chatterjee P, Jakimo N, Lee J, Amrani N, Rodríguez T, Koseki SRT, Tysinger E, Qing R, Hao S, Sontheimer EJ, Jacobson J. Nat Biotechnol; 2020 Oct 01; 38(10):1154-1158. PubMed ID: 32393822 [Abstract] [Full Text] [Related]
40. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview. Karvelis T, Gasiunas G, Siksnys V. Methods; 2017 May 15; 121-122():3-8. PubMed ID: 28344037 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]